LaFrence Andrew D.C. 4
4 · Vyant Bio, Inc. · Filed May 21, 2021
Insider Transaction Report
Form 4
Vyant Bio, Inc.VYNT
LaFrence Andrew D.C.
Chief Financial Officer
Transactions
- Purchase
Common Stock, $0.0001 par value
2021-05-20$3.28/sh+3,000$9,837→ 32,336 total
Holdings
- 26,866(indirect: By Trust)
Common Stock, $0.0001 par value